Interaction Guide · Research summary

Can I take Psyllium Husk Powder with Semaglutide?

Review Psyllium Husk Powder with Semaglutide: timing and monitoring, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Keep psyllium husk outside the fasting administration window for semaglutide tablets. There is no established reason to avoid it universally with semaglutide injections or to use a specific injection-to-fiber gap.

What this answer covers

Psyllium husk powder, commonly Plantago ovata; not interchangeable with Plantago afra whole seed or a mixed-fiber formula.

Supplement or preparation
Psyllium Husk Powder
Medication ingredient
semaglutide

Tablet timing differs from injection timing

Take a semaglutide tablet on an empty stomach in the morning with up to 4 ounces of plain water. Wait at least 30 minutes before food, drinks or another oral product, including a supplement. Weekly injections do not have this fasting or 30-minute rule.

Do not combine the powders and tablet dose

Semaglutide tablets are swallowed whole with up to 4 ounces of plain water. Take fiber later according to its own fluid instructions rather than mixing it into the semaglutide dose or restricting the fiber’s required fluid.

A registered fiber study does not settle the question

A trial registry describes injected semaglutide with a mixture of psyllium, glucomannan and inulin. No results were posted in the inspected record. It cannot establish the safety or benefit of isolated husk, or a protective spacing interval.

Review persistent gastrointestinal symptoms

Semaglutide has gastrointestinal precautions, including severe gastroparesis. Discuss troublesome symptoms and the actual fiber product with a clinician. A universal avoidance rule is not supported, and spacing alone does not establish safety.

Evidence and practical considerations

Timing & monitoring

Conditional oral-tablet timing supported by current exact labels and co-tablet pharmacokinetic study; no increased supplement need, universal avoidance or injection gap established.

Exact scope
Psyllium husk powder, commonly Plantago ovata; not interchangeable with Plantago afra whole seed or a mixed-fiber formula. with Semaglutide RxCUI 1991302 IN; exact oral-tablet and subcutaneous formulation boundaries.
Medication form and route
oral medication; subcutaneous medication; oral supplement

What remains uncertain

  • No supplement-specific percentage, event rate, nutrient requirement or injection gap established.

Factors that may matter: Formulation; Preparation; Insulin or sulfonylurea co-use; Gastrointestinal symptoms.

Research conclusion: supported with conditions · Evidence assessment: moderate

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: Patients prescribed the named semaglutide formulation

Glucose-dependent insulin/glucagon effects; hypoglycemia risk with insulin/secretagogues. Gastric-emptying precautions. Oral tablets require fasting morning dosing with up to 4 ounces plain water and at least 30 minutes before other oral medicines, food or drink. Weekly injections can be given with or without meals.

How this applies: Exact named semaglutide formulation; oral and subcutaneous administration distinguished.

No ingredient-specific supplement interaction or routine nutrient need established. Tablet strengths/formulations not automatically interchangeable; injection has no tablet fasting rule.

Source 2: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: Patients prescribed the named semaglutide formulation

Weekly subcutaneous dosing with or without meals. Glucose-dependent effects; hypoglycemia risk with insulin/secretagogues. Gastric emptying delayed but studied oral drugs had no clinically relevant absorption effect.

How this applies: Exact named semaglutide formulation; oral and subcutaneous administration distinguished.

No ingredient-specific supplement interaction or routine nutrient need established. Tablet strengths/formulations not automatically interchangeable; injection has no tablet fasting rule.

Source 3: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: Patients prescribed the named semaglutide formulation

Glucose-dependent insulin/glucagon effects; hypoglycemia risk with insulin/secretagogues. Gastric-emptying precautions. Oral tablets require fasting morning dosing with up to 4 ounces plain water and at least 30 minutes before other oral medicines, food or drink. Weekly injections can be given with or without meals.

How this applies: Exact named semaglutide formulation; oral and subcutaneous administration distinguished.

No ingredient-specific supplement interaction or routine nutrient need established. Tablet strengths/formulations not automatically interchangeable; injection has no tablet fasting rule.

Source 4: original human pharmacokinetic study

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: 45 healthy participants in two-part study

Co-administration with placebo tablets reduced semaglutide exposure by 34%. Levothyroxine exposure increased in a different comparison.

How this applies: Supports oral administration conditions, not herb-specific pharmacokinetics or clinical harm.

Placebo tablets, not any named supplement. Not injected semaglutide or a proven percentage effect for current different tablet formulations. Abstract only.

Source 5: clinical trial registry

clinicaltrials.gov · Source check Sep 10, 2026

Population: Planned study in obesity with semaglutide treatment

Registry reports completed status but no posted results.

How this applies: Registered mixed-fiber and injected-semaglutide study; no outcome evidence for isolated husk.

A protocol is not outcome evidence. Mixed fiber is not isolated psyllium husk; cannot establish safety, benefit or timing.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Prepared exact semaglutide article distinguishing oral administration, injected treatment and supplement-specific evidence.
Research summary published

Article revision: 8624043564876c0c

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.